REPL Stock Analysis: Buy, Sell, or Hold?
REPL - Replimune Group, Inc.
$5.01
-0.21 (-4.02%)
▼
5d:
+33.96%
30d:
+130.88%
90d:
-30.99%
WAIT
LOW Confidence
Analysis Updated: May 18, 2026 12:00 AM ET
Earnings: May 28, 2026
9d
Smart Money Accumulation
REPL is down 9.8% this week, but smart money is accumulating calls. Top strike: $3 2026-06-18 with 1,548 OI. Call ratio: 99% View Scanner →
Strength: 9.8/10
Get Alerted When REPL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
5 traders called REPL this week
58% bullish • 5 bearish
58% bullish • 5 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: REPL is 13.3% above its trading range ($4.42). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: REPL is 13.3% above its trading range ($4.42). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: REPL is currently trading at $5.01, which is considered extended relative to its 30-day fair value range of $2.02 to $4.42.
Technical Outlook: Technically, REPL is in a strong downtrend. Immediate support is located at $2.52, while resistance sits at $5.54. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: REPL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $3.50. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, REPL is in a strong downtrend. Immediate support is located at $2.52, while resistance sits at $5.54. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: REPL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $3.50. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.02 -
$4.42
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
36.8%
Protect Your Profits
Holding REPL? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+13.3% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.0%)
- BEARISH: Trading 33.0% above Wall St target ($3.50)
Trading Range Analysis
30-Day Trading Range
$2.02 -
$4.42
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.52
Resistance Level
$5.54
Current Trend
Strong Downtrend
Technical data as of
May 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.51
Wall Street Target
$3.50
(-33.0%)
Share & Embed Analysis
Last updated: May 18, 2026 4:22 PM ET
Data refreshes hourly during market hours. Next update: 5:22 PM
Data refreshes hourly during market hours. Next update: 5:22 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is REPL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Christopher Sarchi
SELL
6500 shares
2026-04-02
Kapil Dhingra
SELL
3169 shares
2025-12-09
Sushil Patel
SELL
10000 shares
2025-12-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 63 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 56 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$875 | 45 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$242 | 64 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 53 HOLD |
Advanced REPL Option Strategies
Professional options setups generated by AI based on today's REPL price and gamma walls.
